- Welcome to CRYSTOMED-Pharma
- Plot 397,1st Floor Industrial area, Phase-1 Panchkula
- info@crystomed.com
- +91-99151-23402
No images found for the gallery.
LETRIX
Tablet
Composition
Letrozole 2.5mg
Letrozole 2.5mg | Letrozole, an aromatase inhibitor, is prescribed in 2.5mg dosage for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
Letrozole, an aromatase inhibitor, is prescribed in 2.5mg dosage for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
MRP: ₹3300
100%
Certified Products
Secure
Payments
24/7
Customer Support
About The Product
Description
Letrozole, an aromatase inhibitor, is prescribed in 2.5mg dosage for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen levels, hindering the growth of hormone-sensitive tumors. Letrozole is often used as part of adjuvant therapy following surgery or as a first-line treatment for advanced breast cancer.
Side Effects
- While effective in its intended use, Letrozole may cause side effects, including hot flashes, joint pain, and fatigue. More serious side effects may include bone thinning and an increased risk of fractures. It's crucial to take the medication as directed and report any persistent or severe symptoms to your healthcare provider promptly.
Important Notice
Indications
- Postmenopausal Breast Cancer: Prescribed as a hormonal therapy for postmenopausal women with hormone receptor-positive breast cancer.
- Adjuvant Therapy: Used as part of adjuvant therapy to prevent cancer recurrence following surgery.
- Advanced Breast Cancer: Letrozole may be a first-line treatment for advanced breast cancer in postmenopausal women.
- Postmenopausal Breast Cancer: Prescribed as a hormonal therapy for postmenopausal women with hormone receptor-positive breast cancer.
- Adjuvant Therapy: Used as part of adjuvant therapy to prevent cancer recurrence following surgery.
- Advanced Breast Cancer: Letrozole may be a first-line treatment for advanced breast cancer in postmenopausal women.
Storage Condition
You will get complete details about the storage conditions of the product on the packing, which you can check on the back side of the box.
Indications
- Postmenopausal Breast Cancer: Prescribed as a hormonal therapy for postmenopausal women with hormone receptor-positive breast cancer.
- Adjuvant Therapy: Used as part of adjuvant therapy to prevent cancer recurrence following surgery.
- Advanced Breast Cancer: Letrozole may be a first-line treatment for advanced breast cancer in postmenopausal women.
Storage Condition
You will get complete details about the storage conditions of the product on the packing, which you can check on the back side of the box.
